Search hospitals > Arizona > Phoenix
Mayo Clinic Arizona
Claim this profilePhoenix, Arizona 85054
Global Leader in Cancer
Global Leader in Colorectal Cancer
Conducts research for Lung Cancer
Conducts research for Solid Tumors
Conducts research for Breast Cancer
493 reported clinical trials
98 medical researchers
Summary
Mayo Clinic Arizona is a medical facility located in Phoenix, Arizona. This center is recognized for care of Cancer, Colorectal Cancer, Lung Cancer, Solid Tumors, Breast Cancer and other specialties. Mayo Clinic Arizona is involved with conducting 493 clinical trials across 838 conditions. There are 98 research doctors associated with this hospital, such as Steven Attia, MD, Carola A. Arndt, Mahesh Seetharam, and Arkadiusz Dudek, MD.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
RET
2Colorectal Cancer
Global LeaderStage IV
Stage III
BRAF positive
Top PIs
Steven Attia, MDMayo Clinic2 years of reported clinical research
Expert in Soft Tissue Sarcoma
Studies Synovial Sarcoma
32 reported clinical trials
44 drugs studied
Carola A. ArndtMayo Clinic in Rochester8 years of reported clinical research
Expert in Cancer
Expert in Neuroblastoma
26 reported clinical trials
49 drugs studied
Mahesh SeetharamMayo Clinic2 years of reported clinical research
Studies Cancer
Studies Melanoma
21 reported clinical trials
31 drugs studied
Arkadiusz Dudek, MDRegions Cancer Care Center5 years of reported clinical research
Studies Lung Cancer
Studies Solid Tumors
14 reported clinical trials
23 drugs studied
Clinical Trials running at Mayo Clinic Arizona
Lung Cancer
Breast Cancer
Skin Cancer
Prostate Cancer
Ovarian Cancer
Bladder Cancer
Cancer
Melanoma
Colorectal Cancer
Myelofibrosis
Telisotuzumab Vedotin vs. Docetaxel
for Non-Small Cell Lung Cancer
This trial is testing a new drug called telisotuzumab vedotin to see if it can treat a specific type of lung cancer better than an existing drug. The study focuses on adults whose lung cancer has not responded to previous treatments. The new drug targets and kills cancer cells by attaching to a specific protein on their surface.
Recruiting2 awards Phase 312 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Treatment Timing
for Non-Small Cell Lung Cancer
This phase III trial compares standard therapy given after surgery (adjuvant) to standard therapy given before and after surgery (perioperative) in treating patients with stage II-IIIB non-small cell lung cancer (NSCLC) that can be removed by surgery (resectable). The usual approach for patients with resectable NSCLC is chemotherapy and/or immunotherapy before surgery, after surgery, or both before and after surgery. This study is being done to find out which approach is better at treating patients with lung cancer. Treatment will be administered according to the current standard of care at the time of enrollment. Chemotherapy options may include cisplatin, carboplatin, pemetrexed, gemcitabine, docetaxel, and vinorelbine at standard doses according to the treating physician. Cisplatin is in a class of medications known as platinum-containing compounds. It works by killing, stopping or slowing the growth of tumor cells. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of tumor cells. Pemetrexed is in a class of medications called antifolate antineoplastic agents. It works by stopping cells from using folic acid to make deoxyribonucleic acid (DNA) and may kill tumor cells. Gemcitabine is a chemotherapy drug that blocks the cells from making DNA and may kill tumor cells. Docetaxel is in a class of medications called taxanes. It stops tumor cells from growing and dividing and may kill them. Other chemotherapy drugs, such as vinorelbine, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading . Immunotherapy with monoclonal antibodies, such as nivolumab, pembrolizumab, and atezolizumab, may help the body's immune system attack the tumor, and may interfere with the ability of tumor cells to grow and spread. Starting treatment with chemotherapy and immunotherapy prior to surgery and continuing treatment after surgery may be a more effective treatment option than adjuvant therapy alone in patients with stage II-IIIB resectable NSCLC.
Recruiting2 awards Phase 34 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Mayo Clinic Arizona?
Mayo Clinic Arizona is a medical facility located in Phoenix, Arizona. This center is recognized for care of Cancer, Colorectal Cancer, Lung Cancer, Solid Tumors, Breast Cancer and other specialties. Mayo Clinic Arizona is involved with conducting 493 clinical trials across 838 conditions. There are 98 research doctors associated with this hospital, such as Steven Attia, MD, Carola A. Arndt, Mahesh Seetharam, and Arkadiusz Dudek, MD.
Where is Mayo Clinic Arizona located?
**Directions to Mayo Clinic Hospital, Phoenix, Arizona:**
- From I-10 E, exit onto 40th St and head north.
- Turn right onto E Mayo Blvd.
- The hospital is located at 5777 E Mayo Blvd.
Who should I call to ask about financial aid or insurance network?
For financial assistance at Mayo Clinic Arizona, contact Patient Account Services at 844-217-9591, available Monday through Friday, 8 a.m. to 5 p.m. Mountain time. Applications can be submitted electronically or by mailing the Mayo Clinic Financial Assistance Application (PDF) with supporting documentation. Visit Registration and Business Services at Mayo Clinic in Arizona, Scottsdale campus, Specialty Building, Phoenix campus, or Mayo Clinic Hospital, Phoenix campus for in-person inquiries.
What insurance does Mayo Clinic Arizona accept?
The Mayo Clinic Arizona accepts a variety of insurance plans, including but not limited to Aetna, Blue Cross Blue Shield, Cigna, Coventry, Humana, and UnitedHealthcare International. Coverage for care provided by Mayo Clinic is determined by the individual's insurance company and their specific medical benefit plan. For the most accurate and current information regarding insurance coverage, it is recommended to contact the insurance carrier directly.
What awards or recognition has Mayo Clinic Arizona received?
Mayo Clinic Arizona, located in Phoenix, Arizona, has been awarded its second Magnet designation for nursing excellence by the American Nurses Credentialing Center. This recognition highlights the hospital's commitment to high standards in clinical practice and patient care. Furthermore, Mayo Clinic is celebrated for its dedication to diversity and inclusion, earning the title of 'Best Place To Work For Disability Inclusion' and ranking No. 4 among 'Top Hospitals and Health Systems' by DiversityInc.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.